Home / Brand archive
7 reported ongoing
54 records in this archive. Latest source date Aug 3, 2026.
FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
Failed content uniformity specifications.
Class IIReported ongoing
Distribution: USA Nationwide
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
Class IIReported ongoing
Distribution: Nationwide within the U.S.
Presence of Foreign Substance
Class IIReported ongoing
Distribution: U.S. Nationwide
Presence of particulate matter: a white thread-like structure in the cartridge
Class IIReported ongoing
Distribution: Nationwide within U.S
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
Class IIReported ongoing
Distribution: FL, MA, MI & OH
Defective container - seal not adhering to bottles
Class IIReported ongoing
Distribution: Nationwide.
Labeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027
Class IIReported terminated
Distribution: Nationwide in the US
Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.
Class IIReported terminated
Distribution: Nationwide.
Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.
Class IIReported ongoing
Distribution: Product was distributed nationwide within the United States.
Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month long term stability study.
Class IIReported terminated
Distribution: USA nationwide
Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.
Class IIReported terminated
Distribution: One US distributor in Ohio.
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Class IIReported terminated
Distribution: Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Class IIReported terminated
Distribution: Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Class IIReported terminated
Distribution: Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.
Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
Class IIReported terminated
Distribution: USA nationwide.
Failed Content Uniformity Specifications
Class IIReported terminated
Distribution: Nationwide in the US
Defective container: lack of seal integrity.
Class IIReported terminated
Distribution: USA Nationwide
Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.
Class IIReported terminated
Distribution: USA nationwide
Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.
Class IIReported terminated
Distribution: USA nationwide
Subpotent Drug
Class IIReported terminated
Distribution: Nationwide within the United States
These examples come from this result page and are not a ranking of every recall reason.
This archive contains 54 records, including 7 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.
Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.
A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.
This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.
Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.